Jonathan M. Loree, Jeanne Tie, Emmanuelle Samalin, Sharlene Gill, Benny Johnson, Joseph Elan Grossman, Steven O'Day, Eric Xueyu Chen, Christos Stelios Karapetis, Christelle de la Fouchardière, Winson Y. Cheung, Kelvin K. Chan, Catherine Rutledge, Dongsheng Tu, Christopher J. O'Callaghan. "The CO.33/BATTMAN trial: A phase 3 randomized study of botensilimab + balstilimab versus best supportive care in chemorefractory unresectable colorectal adenocarcinoma that is not dMMR/MSI-H.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps3676